KB
The startup develops therapeutic compounds specifically targeting inflammatory urological diseases, such as interstitial cystitis and painful bladder syndrome. By focusing on unmet medical needs, the company provides patients with effective treatment options that enhance their quality of life.
Updated 3 months ago
Funding
$3.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops therapeutic compounds specifically targeting inflammatory urological diseases, such as interstitial cystitis and painful bladder syndrome. By focusing on unmet medical needs, the company provides patients with effective treatment options that enhance their quality of life.